Science1 min read

A common osteoporosis drug blocked spinal damage in a surprising new study

By · Published by Everything Blog

In short

Currently, patients suffering from severe spinal disc damage have no pharmaceutical options and must rely entirely on surgical interventions. To understand the underlying biology, scientists analyzed zebrafish lacking a functional collagen IX gene, which maintains the structural integrity of discs. The team observed that the breakdown of an underlying support layer triggers harmful mineralization as the fish age. Halting this abnormal mineral deposit process with an established osteoporosis drug preserved spinal health and identified specific metabolic targets for future therapies.

Key points

  • Existing pharmaceuticals approved for other diseases could potentially be repurposed to t…: Existing pharmaceuticals approved for other diseases could potentially be repurposed to treat spinal disc degeneration.
  • Halting abnormal mineral deposits prevents spinal tissues from hardening and keeps verteb…: Halting abnormal mineral deposits prevents spinal tissues from hardening and keeps vertebrae from fusing together.
  • Human trials are still required to confirm whether these animal findings will successfull…: Human trials are still required to confirm whether these animal findings will successfully translate to clinical therapies.

Sources checked by our analysis pipeline: 1

- Date:

- November 15, 2026

- Source:

- University of Edinburgh

- Summary:

- Scientists have uncovered a surprising genetic connection to spinal degeneration and found that an existing osteoporosis drug can prevent damaging mineral buildup in zebrafish spines. The discovery could pave the way for new treatments that slow or prevent a major cause of chronic back pain.

- Share:

An existing osteoporosis drug has shown surprising promise in protecting the spine from damage, raising hopes for new treatments for chronic neck and back pain. In experiments involving zebrafish, researchers found that the medication prevented abnormal mineral deposits from forming in the spine, a process that can cause spinal tissues to harden and vertebrae to fuse together.

The discovery could help scientists tackle one of the underlying causes of back pain: the gradual deterioration of the discs that cushion the bones of the spine. Researchers also identified changes in gene activity and metabolism that appear to contribute to this damage, revealing several possible targets for future treatments.

Although the findings have not yet been confirmed in humans, they…

Science